Sumitomo Chemical's Indian unit; makes crop-protection agrochemicals and animal nutrition products.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 499 | 499 | 499 | 499 | 499 | 499 | 499 | 499 |
| Reserves | 710 | 1.0k | 1.4k | 1.9k | 1.9k | 2.4k | 2.7k | 2.9k |
| Borrowings | 36 | 33 | 38 | 34 | 25 | 45 | 49 | 53 |
| Other Liabilities | 848 | 1.1k | 1.0k | 955 | 822 | 988 | 1.2k | 997 |
| Total Liabilities | 2.1k | 2.7k | 3.0k | 3.4k | 3.3k | 3.9k | 4.4k | 4.4k |
| AssetsFixed Assets | 319 | 309 | 390 | 430 | 489 | 482 | 487 | 499 |
| CWIP | 10 | 14 | 35 | 71 | 23 | 28 | 14 | 20 |
| Investments | 87 | 291 | 357 | 239 | 425 | 601 | 1.3k | 1.2k |
| Other Assets | 1.7k | 2.0k | 2.2k | 2.6k | 2.4k | 2.8k | 2.6k | 2.7k |
| Total Assets | 2.1k | 2.7k | 3.0k | 3.4k | 3.3k | 3.9k | 4.4k | 4.4k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 75 | 222 | 424 | 223 | 389 | 756 | 458 | 443 |
| Cash from Investing | -35 | -118 | -282 | -281 | -327 | -426 | -405 | -329 |
| Cash from Financing | -65 | -61 | -47 | -63 | -73 | -331 | -65 | -81 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 36 | 184 | 382 | 111 | 270 | 695 | 431 | 404 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (50.1×) and current (46.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 2.6% growth and a 46× exit, ₹539 only delivers your return if you pay ₹253. The price is currently baking in 18% growth.
EPS grows 2.6%/yr for 5 years, then fades to 6% over 2, exits at 46×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 2.6% | 11.92 |
| FY28 | 2.6% | 12.23 |
| FY29 | 2.6% | 12.55 |
| FY30 | 2.6% | 12.88 |
| FY31 | 2.6% | 13.21 |
| FY32 | 4.3% ·fade | 13.78 |
| FY33 | 6.0% ·fade | 14.61 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.